Senior insider sale
Principal Accounting Officer at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$1.56M
87.33K shares
What this filing means
DUNN EDMUND plans to sell 87.33K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $1.56M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/16/2026ACC: 0001950047-26-003550
Officer· Principal Accounting Officer
Since Mar 2026
87.33K
Shares to sell
$1.56M
Approx. market value
18.68K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/16/2026
18.68KTotal acquired18.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/16/2026 | Stock Option Exercise Cash | 18.68K | — |
| Total | 18.68K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
16.69K
Market value
$300.4K
4/13/2026
—Completed
Units to sell
26.12K
Market value
$450.6K
4/8/2026
—Completed
Units to sell
139.00
Market value
$2.5K
3/4/2026
—Completed
Units to sell
536.00
Market value
$9.4K
3/2/2026
—Completed
Units to sell
25.16K
Market value
$455.5K
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.68K
Market value
$345.6K
4/16/2026
Total
Units
87.33K
Value
$1.56M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/13/2026 | 16.69K | $300.4K | — | Completed |
4/8/2026 | 26.12K | $450.6K | — | Completed |
3/4/2026 | 139.00 | $2.5K | — | Completed |
3/2/2026 | 536.00 | $9.4K | — | Completed |
2/27/2026 | 25.16K | $455.5K | — | Completed |
| Planned — Approximate Date | ||||
4/16/2026 | 18.68K | $345.6K | NASDAQ | Planned |
| Total | 87.33K | $1.56M | ||